Extracellular vesicles in thalassemia: Mechanisms, implications, and therapeutic potential

Thalassemia is one of the most common inherited disorders of erythrocytes, caused by abnormalities in the production of globin chains. The clinical spectrum of thalassemia is broad, ranging from severe and persistent anemia that necessitates consistent blood transfusions to mild, asymptomatic condit...

Full description

Saved in:
Bibliographic Details
Main Author: Shahzad Ali Jiskani
Format: Article
Language:English
Published: Elsevier 2025-06-01
Series:Aspects of Molecular Medicine
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2949688824000285
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841561257174368256
author Shahzad Ali Jiskani
author_facet Shahzad Ali Jiskani
author_sort Shahzad Ali Jiskani
collection DOAJ
description Thalassemia is one of the most common inherited disorders of erythrocytes, caused by abnormalities in the production of globin chains. The clinical spectrum of thalassemia is broad, ranging from severe and persistent anemia that necessitates consistent blood transfusions to mild, asymptomatic conditions. Key contributors to thalassemia complications, particularly, in patients with β-thalassemia major, are ineffective erythropoiesis and iron overload. These complications can lead to a variety of severe health issues, including chronic inflammation, organ dysfunction, thrombosis, vascular abnormalities, and systemic iron overload. Extracellular vesicles (EVs) are tiny membrane-bound particles secreted from the plasma membranes of various cells during activation and cell death. Research has indicated that EVs are involved in numerous physiological and pathological processes, including inflammatory responses, clot formation, and vascular injury. Recently, the role of EVs has garnered interest of their potential as biomarkers, providing diagnostic and prognostic value of various disorders. In the context of thalassemia, elevated levels of EVs have been observed, highlighting their significance in the disease's cellular activities. The current review aims to examine the role of EVs in the pathogenesis of thalassemia, their implications, and their potential clinical applications. By exploring the involvement of EVs in the inflammatory and vascular complications associated with thalassemia, this review provides insights into their potential as therapeutic targets and diagnostic tools, offering a new perspective on managing this complex and multifaceted disorder.
format Article
id doaj-art-579dc700c6394b6bbfc3c9d3ae01e6ed
institution Kabale University
issn 2949-6888
language English
publishDate 2025-06-01
publisher Elsevier
record_format Article
series Aspects of Molecular Medicine
spelling doaj-art-579dc700c6394b6bbfc3c9d3ae01e6ed2025-01-03T04:09:04ZengElsevierAspects of Molecular Medicine2949-68882025-06-015100061Extracellular vesicles in thalassemia: Mechanisms, implications, and therapeutic potentialShahzad Ali Jiskani0School of Medicine, Shenzhen University, Guangdong, China; Dept. of Pathology, Chandka Medical College @ SMBBMU Larkana, Sindh, Pakistan; School of Medicine, Shenzhen University, Guangdong, China.Thalassemia is one of the most common inherited disorders of erythrocytes, caused by abnormalities in the production of globin chains. The clinical spectrum of thalassemia is broad, ranging from severe and persistent anemia that necessitates consistent blood transfusions to mild, asymptomatic conditions. Key contributors to thalassemia complications, particularly, in patients with β-thalassemia major, are ineffective erythropoiesis and iron overload. These complications can lead to a variety of severe health issues, including chronic inflammation, organ dysfunction, thrombosis, vascular abnormalities, and systemic iron overload. Extracellular vesicles (EVs) are tiny membrane-bound particles secreted from the plasma membranes of various cells during activation and cell death. Research has indicated that EVs are involved in numerous physiological and pathological processes, including inflammatory responses, clot formation, and vascular injury. Recently, the role of EVs has garnered interest of their potential as biomarkers, providing diagnostic and prognostic value of various disorders. In the context of thalassemia, elevated levels of EVs have been observed, highlighting their significance in the disease's cellular activities. The current review aims to examine the role of EVs in the pathogenesis of thalassemia, their implications, and their potential clinical applications. By exploring the involvement of EVs in the inflammatory and vascular complications associated with thalassemia, this review provides insights into their potential as therapeutic targets and diagnostic tools, offering a new perspective on managing this complex and multifaceted disorder.http://www.sciencedirect.com/science/article/pii/S2949688824000285Extracellular vesiclesThalassemiaRed blood cellsExosomes
spellingShingle Shahzad Ali Jiskani
Extracellular vesicles in thalassemia: Mechanisms, implications, and therapeutic potential
Aspects of Molecular Medicine
Extracellular vesicles
Thalassemia
Red blood cells
Exosomes
title Extracellular vesicles in thalassemia: Mechanisms, implications, and therapeutic potential
title_full Extracellular vesicles in thalassemia: Mechanisms, implications, and therapeutic potential
title_fullStr Extracellular vesicles in thalassemia: Mechanisms, implications, and therapeutic potential
title_full_unstemmed Extracellular vesicles in thalassemia: Mechanisms, implications, and therapeutic potential
title_short Extracellular vesicles in thalassemia: Mechanisms, implications, and therapeutic potential
title_sort extracellular vesicles in thalassemia mechanisms implications and therapeutic potential
topic Extracellular vesicles
Thalassemia
Red blood cells
Exosomes
url http://www.sciencedirect.com/science/article/pii/S2949688824000285
work_keys_str_mv AT shahzadalijiskani extracellularvesiclesinthalassemiamechanismsimplicationsandtherapeuticpotential